Catalog Number
Main Products
Molecular Weight
Molecular Formula

If you have any other questions or need other size, please get a quote.

  • Product Description
  • Case Study
  • Custom Reviews
  • Custom Q&A
  • Synthetic Use
  • Related Resources


TAK875;3-Benzofuranacetic acid, 6-[[2,6-diMethyl-4-[3-(Methylsulfonyl)propoxy][1,1-biphenyl]-3-yl]Methoxy]-2,3-dihydro-, (3S)-;(3S)-6-[[2,6-Dimethyl-4-[3-(methylsulfonyl)propoxy][1,1-biphenyl]-3-yl]methoxy]-2,3-dihydro-3-benzofuranacetic acid;TAK-875,TAK875;[(3S)-6-({2,6-Dimethyl-4-[3-(methylsulfonyl)propoxy]-3-biphenylyl}methoxy)-2,3-dihydro-1-benzofuran-3-yl]acetic acid;(S)-2-(6-((2,6-Dimethyl-4-(3-(methylsulfonyl)propoxy)-[1,1-biphenyl]-3-yl)methoxy)-2,3-dihydrobenzofuran-3-yl)acetic acid;TAK-875, >=98%;Fasiglifam
Canonical SMILES
InChI Key
Exact Mass

TAK-875 Induces Hepatotoxicity Through Generation of Reactive Oxygen Species in A GPR40-Dependent Manner

Kim M J, et al. Biomolecules & Therapeutics, 2018, 26(6), 599.

TAK-875 is a G protein-coupled receptor 40 (GPR40) agonist that significantly improves hyperglycemia. However, hepatotoxicity of TAK-875 led to the early termination of its development. The direct hepatotoxicity of TAK-875 can be assessed through in vitro 2D and 3D HepG2 culture models. TAK-875 reduces the viability of human hepatoma cell line HepG2 2D and 3D cultures in a concentration (>50 μM) and time-dependent manner, both corresponding to ROS production.
Cell processing steps
· Cells were treated with varying concentrations of TAK-875, APAP, or DMSO (final 0.5%) in culture medium for 24 h.
· The control group was treated with only 0.5% DMSO. Fibroblasts were seeded into 6-well plates at a density of 1.5×10 5 /well, while HepG2 cells were seeded into 96-well plates at a density of 1.0×10 4 /well.
· For ROS assay, each cell line was seeded in 6-well plates at 1.5 × 10 5 /well.

TAK-875 Improves Cognitive Deficits and Reduces Beta-Amyloid Production in Mice

Liu C, et al. Psychopharmacology, 2021, 238(8), 2133-2146.

TAK-875 is a G protein-coupled receptor 40 (GPR40) agonist. GPR40 is expressed in brain and peripheral cells and is related to cognitive functions such as spatial orientation, memory and learning. Research suggests that GPR40 may be a potential therapeutic target for AD. TAK-875, as a GPR40 agonist, has the potential to become a drug for Alzheimer's disease (AD).
The activation of GPR40 by TAK-875 can effectively rescue cognitive deficits in APPswe/PS1dE9 mice. These effects may be mediated by the regulation of PLC/PKC/ADAM10 signaling pathway, which promoted APP non-amyloidogenic processing pathway and reduced Aβ production.
Experiment content
· Fifty APPswe/PS1dE9 mice and 10 wild-type littermates were randomly divided into 6 groups for experiments with different administration methods.
· The TAK-875, GW1100, and normal saline (NS) were administered intracerebroventricularly once per day for 7 consecutive days through an intracerebroventricular administration system.
· The infusion volume for each medication every day was 5 μl, but in GW1100 + TAK-H group, to exclude interference factor from infusion volume, the infusion volume for each drug was 2.5 μl.
· In addition, the mice in GW1100 + TAK-H group were initially treated with GW1100, and then with TAK-875 30 min later.

Semptember 11, 2022

Work great in research.
Work great in biochemistry research.

What is Isomeric SMILES of Tak875?

It is CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=CC4=C(C=C3)[C@@H](CO4)CC(=O)O)C)OCCCS(=O)(=O)C.

What is EC number of Tak875?


What is exact mass of Tak875?


What is molecular formula of Tak875?


Alfa Chemistry

For product inquiries, please use our online system or send an email to .

Alfa Chemistry
Inquiry Basket
Verification code
* I hereby give my consent that I may receive marketing e-mails with information on existing and new services from this company. I know that I can opt-out from receiving such e-mails at any time or by using the link which will be provided in each marketing e-mail.